-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: BIO
BIO Hails Senate Passage of America Invents Act
BIO Hails Senate Passage of America Invents Act Bipartisan, consensus-oriented approach will strengthen nation’s patent system and spur innovation, job creation Washington, D.C. (March 8, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on the passage today of the America Invents Act (S. 23) by the U.S. Senate: “BIO commends the Senate for its overwhelming passage of the America Invents Act by a vote of 95-5. We appreciate Read More >
Biofuels Digest, BIO Launch Spring 2011 Bioenergy Business Outlook Survey
Biofuels Digest and the Biotechnology Industry Organization (BIO) invite the industry to take part in the Spring 2011 Bioenergy Business Outlook Survey. The survey examines growth expectations and opportunities from a company, national and organizational point of view. It also examines the role of research, government policy, finance, and research and market partners in creating opportunities or barriers to the growth of green jobs, energy security and reductions in greenhouse gas emissions. The survey is Read More >
2011 BIO International Convention Super Sessions
2011 BIO International Convention Super Sessions Focus on State of the Industry C-Level speakers lead broad conversations on global biotech, industry forecast, and key trends WASHINGTON, D.C. (March 2, 2011) — The 2011 BIO International Convention will feature six high-level super sessions focused on the state of the industry, global biotech advancements and the outlook on the future of the industry. Hosted by the Biotechnology Industry Organization (BIO), the global event for biotechnology will take Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: BIO, BIO International Convention, Bio-Innovation Scorecard, Biologics, biotechnology, Biotechnology Industry Organization, Biotechnology Industry Report, Biotechnology Innovation Ecosystem, Biotechnology Trade Expo, Burrill, Campbell Alliance, Dealmakers' Intentions, Eli Lilly and Company, emerging markets, Ernst & Young, Fareed Zakaria, global biotech, Jim Greenwood, Merck, Scientific American, State-of-the-Industry Report, Super Sessions
Tags: BIO, BIO International Convention, Bio-Innovation Scorecard, Biologics, biotechnology, Biotechnology Industry Organization, Biotechnology Industry Report, Biotechnology Innovation Ecosystem, Biotechnology Trade Expo, Burrill, Campbell Alliance, Dealmakers' Intentions, Eli Lilly and Company, emerging markets, Ernst & Young, Fareed Zakaria, global biotech, Jim Greenwood, Merck, Scientific American, State-of-the-Industry Report, Super Sessions
BIO Comments to USTR on 2011 Special 301 Review
BIO Comments to USTR on 2011 Special 301 Review (February 15, 2011) In comments to the U.S. Trade Representative (USTR), BIO stresses the critical importance of protecting intellectual property abroad and made recommendations about which countries to include on the Priority Watch and Watch List, which to elevate as a Priority Foreigh Country, and which countries to monitor. Read the Comments (link to http://bio.org/pdfs/BIO_2011_Special_301_Submission.pdf) Read the Press Release (link to http://bio.org/news/pressreleases/newsitem.asp?id=2011_0221_01)
Counterfeiting and Piracy put 2.5 million legitimate jobs at risk each year.
Interesting study out of the International Chamber of Commerce stating that the global economic and social impacts of counterfeiting and piracy will reach US$1.7 trillion by 2015 and put 2.5 million legitimate jobs at risk each year. This builds off a previous OECD study and uses the same formulas. Other Highlights: -G20 countries lose $77.5 billion in tax revenues, lose $25 billion to increased costs of crime, lose $18.1 billion costs of deaths related to counterfeits, Read More >
